This
website has previously reported on forthcoming change to the European
Pharmacopeia on the use of reverse osmosis, in addition to distillation, for
producing WFI-bulk (Water for Injection).
This
is now spelt out in the applicable monograph “Water for injections (0169)”. The
proposed text reads:
“Water
for injections in bulk is obtained from water that complies with the
regulations on water intended for human consumption laid down by the competent
authority or from purified water.
It
is produced either:
–
by distillation in an apparatus of which the parts in contact with the water
are of neutral glass, quartz or a suitable metal and which is fitted with an
effective device to prevent the entrainment of droplets; The correct
maintenance of the apparatus is essential. the first portion of the distillate
obtained when the apparatus begins to function is discarded and the distillate
is collected; or
–
by reverse osmosis, which may be single-pass or double-pass, coupled with other
suitable
techniques
such as deionisation and/or ultrafiltration.”Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources